Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Bayer Pharma Aktiengesellschaft
Bayer Pharma Aktiengesellschaft xfc xdf
  

Bayer Pharma Aktiengesellschaft patents (2017 archive)

Recent patent applications related to Bayer Pharma Aktiengesellschaft. Bayer Pharma Aktiengesellschaft is listed as an Agent/Assignee. Note: Bayer Pharma Aktiengesellschaft may have other listings under different names/spellings. We're not affiliated with Bayer Pharma Aktiengesellschaft, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "B" | Bayer Pharma Aktiengesellschaft-related inventors




Date Bayer Pharma Aktiengesellschaft patents (2017 archive) (updated weekly) - BOOKMARK this page
11/16/17Synthesis of copanlisib and its dihydrochloride salt
11/09/171-cyclohexyl-2-phenylaminobenzimidazoles as midh1 inhibitors for the treatment of tumors
11/09/17Amide-substituted pyridinyltriazole derivatives and uses thereof
11/09/17Benzimidazol-2-amines as midh1 inhibitors
11/02/17Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereof
11/02/17Substituted pyrazolo[1,5-a]pyridines and imidazo[1,2-a]pyrazines and their use
10/26/17Heteroaryl-substituted imidazo[1,2-a]pyridines and their use
10/26/17Benzyl substituted indazoles as bub1 kinase inhibitors
10/26/17Process for the preparation of 3-phenyl/heteroaryl-6-phenoxy-8-alkylamino-imidazo[1,2-b]pyridazine derivatives
10/19/17Substituted oxopyridine derivatives
10/12/17Substituted oxopyridine derivatives
10/05/17Diaminoheteroaryl substituted indazoles
10/05/17Substituted oxopyridine derivatives
09/28/17Benzyl substituted indazoles as bub1 inhibitors
09/28/17Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancer
09/28/17Heteroaryl substituted indazoles
09/28/17Benzyl substituted indazoles as bub1 kinase inhibitors
09/28/17Benzyl substituted indazoles
09/28/17Factor xia-inhibiting pyridobenzazepine and pyridobenzazocine derivatives
09/21/17Substituted uracils as chymase inhibitors
09/14/17Novel 5-aminotetrahydroquinoline-2-carboxylic acids and their use
09/14/17Substituted n,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents
09/14/17Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases
09/14/173-nitrogen or sulphur substituted oestra-1,3,5(10),16-tetraene akr1c3 inhibitors
09/07/17Substituted pyridobenzodiazepinone-derivatives and use thereof
08/24/17(aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their use
08/24/17Amino-substituted annulated pyrimidines and use thereof
08/17/17Substituted quinoline-4-carboxamides and use thereof
08/17/17Substituted quinoline-4-carboxamides and use thereof
08/17/17Substituted annulated pyrimidines and use thereof
08/10/17Laminate changing device
08/10/17Glucose transport inhibitors
08/10/17Fluorinated benzofuranyl-pyrimidine derivatives containing a suflone group
08/03/172-(morpholin-4-yl)-1,7-naphthyridines
08/03/17Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfoximine group
08/03/17Amino-substituted isoxazoles
08/03/17Cyano-substituted imidazo[1,2-a]pyridinecarboxamides and their use
08/03/17Method for the preparation of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carbox-amide and the purification thereof for use as an active pharmaceutical ingredient
07/27/17Glucose transport inhibitors
07/20/175-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
07/20/17Polyethylene glycol based prodrug of adrenomedullin and use thereof
07/13/17Benzimidazol-2-amines as midh1 inhibitors
07/13/17Benzimidazol-2-amines as midh1 inhibitors
07/13/17Benzothiadiazolamines
06/29/17Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
05/25/17Cyclic thienouracil-carboxamides and use thereof
05/25/17Method for targeted conjugation of peptides and proteins by paired c2 bridging of cysteine amino acids
05/04/17Chiral 2,5-disubstituted cyclopentanecarboxylic acid derivatives and use thereof
05/04/17Heterobicyclically substituted 4-oxobutane acid derivatives and use thereof
05/04/17Bet-protein inhibiting 3,4-dihydropyrido[2,3-b]pyrazinones with meta-substituted aromatic amino- or ether groups
04/27/172,5-disubstituted cyclopentane carboxylic acids for the treatment of respiratory tract diseases
04/27/17Inhibitors of the wnt signalling pathways
04/20/17Novel compounds
04/20/17Substituted tetrahydropyridothienopyrimidines
04/13/173-amino-1,5,6,7-tetrahydro-4h-indol-4-ones
04/13/176-chlorine-substituted imidazo[1,2-a]pyridine carboxamides and the use thereof as soluble guanylate cyclase stimulators
03/23/17Phenyl and benzodioxinyl substituted indazoles derivatives
03/23/17Phenyl and benzodioxinyl substituted indazoles derivatives
03/02/17Substituted imidazo[1,2-a]pyridinecarboxamides and their use
03/02/17Enantiomers of the n-(2-amino-5-fluoro-2-methylpentyl)-8-[(2,6-difluorobenzyl)oxy]-2-methylimidazo[1,2-a]pyridine-3-carboxamide, as well as of the di- and trifluoro derivatives for the treatment of cardiovascular diseases
02/23/17Imidazo[1,2-a]pyridines as soluble guanylate cyclase stimulators for the treatment of cardiovascular diseases
02/23/17Imidazo[1,2-a]pyridines as stimulators of soluble guanylate cyclase for treating cardiovascular diseases
02/09/17Substituted oxopyridine derivatives and use thereof as factor xia/plasma
02/09/17Glucose transport inhibitors
02/02/17Novel macrocyclic compounds
02/02/17Amido-substituted imidazopyridazines useful in the treatment of hyper-proliferative and/or angiogenesis disorders
01/26/17Bicyclically substituted uracils and the use thereof
01/26/17Bicyclically substituted uracils and the use thereof
01/26/17Amido-substituted azole compounds
01/26/172,5-disubstituted cyclopentanecarboxylic acids and their use
01/19/17Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine group
01/12/17Metal chelate compounds for binding to the platelet specific glycoprotein iib/iiia
01/05/175-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Bayer Pharma Aktiengesellschaft in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Bayer Pharma Aktiengesellschaft with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';